John L. Brottem - May 16, 2023 Form 4 Insider Report for Outset Medical, Inc. (OM)

Signature
John L Brottem
Stock symbol
OM
Transactions as of
May 16, 2023
Transactions value $
-$68,024
Form type
4
Date filed
5/17/2023, 06:26 PM
Previous filing
May 5, 2023
Next filing
Jun 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Sale -$26.6K -1.34K -2.17% $19.91 60.3K May 16, 2023 Direct F1
transaction OM Common Stock Options Exercise $13.4K +1.42K +2.35% $9.48 61.7K May 17, 2023 Direct F2
transaction OM Common Stock Sale -$28.4K -1.42K -2.29% $20.08 60.3K May 17, 2023 Direct F2
transaction OM Common Stock Sale -$26.4K -1.32K -2.19% $20.08 58.9K May 17, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.42K -7.15% $0.00 18.4K May 17, 2023 Common Stock 1.42K $9.48 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.
F3 This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.